NO3106176T3 - - Google Patents

Info

Publication number
NO3106176T3
NO3106176T3 NO16183076A NO16183076A NO3106176T3 NO 3106176 T3 NO3106176 T3 NO 3106176T3 NO 16183076 A NO16183076 A NO 16183076A NO 16183076 A NO16183076 A NO 16183076A NO 3106176 T3 NO3106176 T3 NO 3106176T3
Authority
NO
Norway
Application number
NO16183076A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47294919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO3106176(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2012/054387 external-priority patent/WO2013135274A1/en
Application filed filed Critical
Publication of NO3106176T3 publication Critical patent/NO3106176T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO16183076A 2011-12-06 2012-12-06 NO3106176T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11192230 2011-12-06
PCT/EP2012/054387 WO2013135274A1 (en) 2012-03-13 2012-03-13 Aluminium compounds for use in therapeutics and vaccines
EP12795830.4A EP2788023B1 (de) 2011-12-06 2012-12-06 Aluminium verbindungen zur verwendung in therapeutika und impfstoffe

Publications (1)

Publication Number Publication Date
NO3106176T3 true NO3106176T3 (de) 2018-03-10

Family

ID=47294919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO16183076A NO3106176T3 (de) 2011-12-06 2012-12-06

Country Status (15)

Country Link
EP (5) EP3785730B1 (de)
CY (1) CY1119927T1 (de)
DE (1) DE202012012768U1 (de)
DK (6) DK2788023T3 (de)
ES (2) ES2930458T3 (de)
FI (1) FI3785730T3 (de)
HR (1) HRP20171871T1 (de)
HU (1) HUE037325T2 (de)
LT (1) LT3106176T (de)
NO (1) NO3106176T3 (de)
PL (2) PL3106176T3 (de)
PT (2) PT3269386T (de)
RS (1) RS56709B1 (de)
SI (1) SI3106176T1 (de)
WO (1) WO2013083726A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2788023T3 (en) 2011-12-06 2016-12-19 Valneva Austria Gmbh Aluminum compounds for use in therapeutics and vaccines
US9895437B2 (en) 2012-04-18 2018-02-20 Valneva Austria Gmbh Aluminum compounds for use in therapeutics and vaccines
AU2015310932B2 (en) * 2014-09-03 2018-11-22 Intervet International B.V. Attenuated bovine coronavirus and related vaccines
CA3009278A1 (en) 2015-12-23 2017-06-29 Valneva Austria Gmbh Zika virus vaccine
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
KR20190103256A (ko) 2016-12-30 2019-09-04 수트로박스, 인코포레이티드 비자연 아미노산을 갖는 폴리펩타이드-항원 접합체
ES2957939T3 (es) 2017-04-13 2024-01-30 Valneva Austria Gmbh Polipéptidos de OspA multivalentes y métodos y usos relacionados con los mismos
KR20200056982A (ko) 2017-09-21 2020-05-25 발네바 에스이 면역원성 치쿤구니야 바이러스 chikv-델타5nsp3을 포함하는 약제학적 조성물의 생산 방법
US11648304B2 (en) 2017-11-03 2023-05-16 Takeda Vaccines, Inc. Zika vaccines and immunogenic compositions, and methods of using the same
CA3084605A1 (en) 2017-11-30 2019-06-06 Takeda Vaccines, Inc. Method for inactivating zika virus and related methods
WO2020012037A1 (en) 2018-07-13 2020-01-16 Valneva Se Method for rescuing and producing a virus in avian cells
AU2020277661A1 (en) 2019-05-20 2021-10-21 Valneva Se A subunit vaccine for treatment or prevention of a respiratory tract infection
WO2021178321A1 (en) * 2020-03-01 2021-09-10 Dynavax Technologies Corporation Coronavirus vaccines comprising a tlr9 agonist
US20230110516A1 (en) * 2020-03-01 2023-04-13 Dynavax Technologies Corporation Coronavirus vaccines comprising a tlr9 agonist
EP3895729A1 (de) 2020-03-01 2021-10-20 Valneva Austria GmbH Cpg-adjuvanter sars-cov-2-virus-impfstoff
IL296071A (en) 2020-03-01 2022-11-01 Valneva Austria Gmbh Sars-cov-2 virus vaccine with adjuvant cytidine-phosphoguanosine
US20230092650A1 (en) * 2020-03-01 2023-03-23 Dynavax Technologies Corporation Coronavirus vaccines comprising a tlr9 agonist
WO2021204825A2 (en) 2020-04-06 2021-10-14 Valneva Austria Gmbh INACTIVATED SARS-CoV-2 VIRUS VACCINE
US20230398210A1 (en) 2020-04-09 2023-12-14 Valneva Austria Gmbh Improvements in vaccine formulations for medical use
CN117279659A (zh) 2021-04-09 2023-12-22 瓦尔尼瓦公司 人偏肺病毒疫苗
WO2023148256A1 (en) 2022-02-02 2023-08-10 Valneva Austria Gmbh Inactivated sars-cov-2 virus vaccine
WO2023232901A1 (en) 2022-06-01 2023-12-07 Valneva Austria Gmbh Clostridium difficile vaccine
WO2024153686A1 (en) 2023-01-18 2024-07-25 Valneva Austria Gmbh Process for virus production in a bioreactor

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4761372A (en) 1981-01-12 1988-08-02 New York University Mutant enterotoxin of E. coli
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4663160A (en) 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US4761283A (en) 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4882317A (en) 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US5308835A (en) 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
US4808700A (en) 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
NL8802046A (nl) 1988-08-18 1990-03-16 Gen Electric Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
CA2059693C (en) 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
AUPO264096A0 (en) 1996-09-30 1996-10-24 Mclaughlin Geosurveys Pty Ltd. Value improvement of clays
US6818222B1 (en) 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
AU748730B2 (en) 1997-08-28 2002-06-13 Cheil Jedang Corporation An attenuated Japanese encephalitis virus adapted to vero cell and a Japanese encephalitis vaccine
NZ509986A (en) 1998-08-19 2003-10-31 Baxter Healthcare S Immunogenic beta-propionamido-linked polysaccharide and oligosaccharide protein conjugates as vaccines
DK1372708T3 (da) 2001-02-13 2008-10-20 Us Gov Sec Army Vaccine til transkutan immunisering mod rejsediarre
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
US20110189217A1 (en) * 2008-06-26 2011-08-04 Barry Michael A Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance
CN101734698B (zh) 2009-09-08 2013-01-09 东北大学 一种由含铝物料制备氧化铝的方法
DK2788023T3 (en) 2011-12-06 2016-12-19 Valneva Austria Gmbh Aluminum compounds for use in therapeutics and vaccines

Also Published As

Publication number Publication date
PL3269386T3 (pl) 2022-12-05
DE202012012768U1 (de) 2014-01-21
PT3106176T (pt) 2017-12-20
HUE037325T2 (hu) 2018-08-28
DK3785730T3 (da) 2024-05-06
ES2930458T3 (es) 2022-12-13
CY1119927T1 (el) 2018-12-12
PT3269386T (pt) 2022-12-05
DK201300194U1 (da) 2014-01-17
PL3106176T3 (pl) 2018-03-30
DK2788023T3 (en) 2016-12-19
WO2013083726A1 (en) 2013-06-13
EP3269386B1 (de) 2022-09-14
EP2788023A1 (de) 2014-10-15
SI3106176T1 (en) 2018-04-30
LT3106176T (lt) 2018-01-10
DK3269386T3 (da) 2022-10-24
EP2788023B1 (de) 2016-11-02
DK201300193U1 (da) 2014-01-17
EP3269386A1 (de) 2018-01-17
RS56709B1 (sr) 2018-03-30
EP3106176A1 (de) 2016-12-21
ES2647882T3 (es) 2017-12-27
HRP20171871T1 (hr) 2018-01-12
EP3785730B1 (de) 2024-04-24
EP4400115A2 (de) 2024-07-17
EP3785730A1 (de) 2021-03-03
DK3106176T3 (en) 2018-01-08
EP3106176B1 (de) 2017-10-11
FI3785730T3 (fi) 2024-05-06

Similar Documents

Publication Publication Date Title
BR112013022641A2 (de)
AP3853A (de)
BR112013027245A2 (de)
BR112013026905A2 (de)
BR112013023185A2 (de)
BR112013022995A2 (de)
BR112013026744A2 (de)
BR112013017670A2 (de)
BR112013027830A2 (de)
BR112013024365A2 (de)
BR112013027121A2 (de)
BR112013027452A2 (de)
AP2016009466A0 (de)
NO3106176T3 (de)
BR112013024588A2 (de)
BR112013026790A2 (de)
BR112013026895A2 (de)
BR112013018949A2 (de)
BR112013027761A2 (de)
BR112013021637A2 (de)
BR112013025487A2 (de)
BR112013017878A2 (de)
BR112013026861A2 (de)
BR112013027657A2 (de)
BR112013027112A2 (de)